ArticleJournal of clinical practice and research2024
An Unusual Case: Solitary Fibrous Tumor of the Lateral Abdominal Wall Muscles.
Article in Journal of clinical practice and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Solitary fibrous tumor (SFT) is a mesenchymal tissue-based soft tissue tumor known for its potential aggressiveness. SFTs located in the abdominal wall are particularly rare. This report presents a unique case of SFT originating from the muscles of the abdominal wall. Case Report: A 40-year-old male patient was referred to our hospital due to a mass in the left hypochondrium. Abdominal ultrasonography (US) revealed a heterogeneous, hypoechoic tumor with lobulated margins and limited blood supply. Magnetic resonance imaging (MRI) using Gadobutrol (Gadovist® 1.0, Schering AG, Berlin, Germany) demonstrated signal intensity heterogeneity and significant enhancement. The mass was excised en bloc. The specimen was immunopositive for Cluster of Differentiation 34 (CD34), Signal Transducer and Activator of Transcription 6 (STAT-6), desmin, and showed a 10.0% positivity for Ki-67. Follow-up examinations showed no evidence of tumor recurrence. Conclusion: SFTs can display aggressive behavior as they often lack morphological indications of malignancy at the initial stages. For patients diagnosed with SFT, complete surgical excision is curative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.